Form D · Biotechnology
GENTIS INC
Wayne, PA · CIK 0001160108
Offering snapshot reported Jul 19, 2010 · SEC filing
- Reported sold
- $548K Offering amount: $2.25M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 10, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 19, 2010 | Initial | $548,260 | No comparison | 16 | SEC filing |
| Jul 5, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-145172
Source: Form D, filed Jul 19, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David W. Anderson | Director, Executive |
| Charles Cohen | Executive |
| Paul Ducheyne | Director |
| Francisco Garcia | Director |
| Eric W. Linsley | Director |
| Robert Pangia | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
400 East Lancaster Avenue Suite 300
Wayne, PA, 19087
Wayne, PA, 19087